查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607194

葡萄糖胺市場：按類型、形式、來源、應用和分銷管道分類 - 全球預測 2025-2030

Glucosamine Market by Types (Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride), Form (Capsules, Liquid, Powder), Source, Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年葡萄糖胺市場價值為8.048億美元，預計2024年將達到8.4171億美元，複合年成長率為5.28%，到2030年將達到11.4762億美元。

葡萄糖胺是一種對軟骨發育至關重要的天然化合物，因其在關節健康中的作用而被廣泛認可，並且經常用於旨在治療骨關節炎和其他關節相關疾病的補充品中。老化社會、運動員和注重健康的人們對肌肉骨骼健康的認知不斷提高，正在擴大市場基礎。推動葡萄糖胺需求的主要需求是其緩解關節疼痛和提高運動表現的潛力，這使其在製藥、食品和食品補充品行業中受到高度重視。其應用範圍擴展到動物健康，具有廣泛的最終用途，包括幫助解決寵物的類似問題。影響成長的主要趨勢包括預防保健的趨勢、補充品使用的增加以及支持葡萄糖胺益處的持續研究。將葡萄糖胺與軟骨素和 MSM 融合的組合​​補充品等配方創新帶來了巨大的機遇，而意識和健康支出不斷上升的開拓區域市場也是如此。挑戰也依然存在，包括對葡萄糖胺產品功效的擔憂、替代療法等競爭動態以及食品領域的監管審查。在永續性問題的背景下，公司必須應對這些挑戰，以及由於海鮮和貝類來源而導致的原料價格波動。未來的市場擴張可能會受到輸送機制創新的推動，例如透過液化來增加吸收，以及透過純素或合成葡萄糖胺來迎合素食市場。此外，強烈建議相關人員加強臨床測試以支持科學主張，以鞏固其市場地位。整體市場格局多樣化且競爭激烈，這使得策略聯盟和消費者教育成為最大程度地發揮市場格局成長潛力並應對挑戰的重要工具。

主要市場統計
基準年[2023] 80048萬美元
預測年份 [2024] 84171萬美元
預測年份 [2030] 1,147.62 百萬美元
複合年成長率（%） 5.28%

市場動態：揭示快速發展的葡萄糖胺市場的關鍵市場洞察

供需的動態交互作用正在改變葡萄糖胺市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 肥胖人口增加和關節炎患者增加
    • 骨骼和關節保健補充品中葡萄糖胺的使用增加
    • 治療有症狀的膝骨關節炎對葡萄糖胺的需求不斷成長
  • 市場限制因素
    • 與葡萄糖胺產品相關的高成本
  • 市場機會
    • 葡萄糖胺新產品的上市與核准
    • 製造商專注於葡萄糖胺領域的研發活動
  • 市場問題
    • 與葡萄糖胺相關的一些副作用

波特的五力：駕馭葡萄糖胺市場的策略工具

波特的五力框架是了解葡萄糖胺市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解葡萄糖胺市場的外部影響

外部宏觀環境因素在塑造葡萄糖胺市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解葡萄糖胺市場的競爭格局

對葡萄糖胺市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：葡萄糖胺市場供應商的績效評估

FPNV定位矩陣是評估葡萄糖胺市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製葡萄糖胺市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對葡萄糖胺市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3. 塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 肥胖人口增加和關節炎患者數量增加
      • 骨骼和關節保健補充品中葡萄糖胺的使用增加
      • 治療有症狀的膝骨關節炎時對葡萄糖胺的需求不斷增加
    • 抑制因素
      • 與葡萄糖胺產品相關的高成本
    • 機會
      • 葡萄糖胺新產品的上市與核准
      • 製造商專注於葡萄糖胺領域的研發活動
    • 任務
      • 與葡萄糖胺相關的一些副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章葡萄糖胺市場：依類型

  • 介紹
  • 鹽酸鹽葡萄糖胺
  • 葡萄糖胺硫酸鹽氯化鉀
  • 葡萄糖胺硫酸鹽氯化鈉
  • N-乙醯葡萄糖胺

第7章 葡萄糖胺市場：依形式

  • 介紹
  • 膠囊
  • 液體
  • 粉末
  • 錠劑

第8章葡萄糖胺市場：依來源分類

  • 介紹
  • 動物
    • 螃蟹
    • 龍蝦
    • 蝦
  • 植物
    • 玉米
    • 菇

第9章葡萄糖胺市場：依應用分類

  • 介紹
  • 化妝品
  • 食品補充品
  • 保健食品
  • 藥品
  • 獸醫

第10章葡萄糖胺市場：按分銷管道

  • 介紹
  • 網路商店
  • 藥局
  • 零售店
  • 超級市場

第11章美洲葡萄糖胺市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太葡萄糖胺市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的葡萄糖胺市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aden Healthcare
  • Andra Medi Pharma India Pvt. Ltd.
  • Bio-gen Extracts Pvt. Ltd.
  • Captek Softgel International Inc.
  • Cargill, Inc.
  • Cellmark AB
  • Enomark Pharma
  • Ethical Naturals Inc.
  • Fabrichem, Inc.
  • Fermentis Life Sciences
  • GlucosaGreen
  • Golden Shell Pharmaceutical Co. Ltd.
  • Kabir Lifesciences
  • Koyo Chemical Co., Ltd.
  • Lifecare Neuro Products Limited
  • Manus Aktteva Biopharma LLP
  • Panvo Organics Pvt Ltd.
  • Pax Healthcare
  • Schiff Nutrition International Inc.
  • SMPNutra
  • Spectrum Chemical Manufacturing Corp.
  • TSI Health Sciences, Inc.
  • United Laboratories, Inc.
  • Velnex Medicare
  • Wellable Marine BIoTech Holding Limited
  • Zhejiang AOXING BIoTechnology Co., Ltd.
Product Code: MRR-C002B1C994F7

The Glucosamine Market was valued at USD 800.48 million in 2023, expected to reach USD 841.71 million in 2024, and is projected to grow at a CAGR of 5.28%, to USD 1,147.62 million by 2030.

Glucosamine, a natural compound integral to cartilage development, is widely recognized for its role in joint health and often sourced for supplements aimed at managing osteoarthritis and other joint-related ailments. The growing awareness of musculoskeletal health among aging populations, athletes, and health-conscious individuals has expanded the market's reach. A major necessity driving glucosamine demand is its potential to alleviate joint pain and improve mobility, largely appreciated in pharmaceutical, nutraceutical, and food supplements industries. Its application extends to animal health, where it's incorporated to aid similar issues in pets, marking a varied end-use scope. Key factors influencing growth include the trend towards preventive healthcare, an increase in supplement usage, and ongoing research corroborating glucosamine's benefits. Innovations in formulation, such as combination supplements merging glucosamine with chondroitin or MSM, pose substantial opportunities, as do unexplored regional markets where awareness and health expenditure are on the rise. Nevertheless, challenges persist: concerns regarding the efficacy of glucosamine products, competitive dynamics involving alternative therapies, and regulatory scrutiny in the nutraceutical space. Companies must navigate these issues alongside fluctuating raw material prices due to its marine and shellfish origins, against the backdrop of sustainability concerns. Future market expansion can be fueled by innovation in delivery mechanisms, such as liquid form for enhanced absorption and vegan or synthetic glucosamine to cater to vegetarian demographics. Additionally, enhancing clinical trials to reinforce scientific claims serves as a strong recommendation for stakeholders to consolidate market positions. The overall market landscape is diverse and competitive, with strategic alliances and consumer education emerging as critical tools to leverage glucosamine's full growth potential while addressing prevailing market challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 800.48 million
Estimated Year [2024] USD 841.71 million
Forecast Year [2030] USD 1,147.62 million
CAGR (%) 5.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glucosamine Market

The Glucosamine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing obese population coupled with increasing number of arthritis cases
    • Increasing use of glucosamine in bone and joint health supplements
    • Rising need for glucosamine for the treatment of symptomatic osteoarthritis of the knee
  • Market Restraints
    • High cost related to glucosamine products
  • Market Opportunities
    • Launch and approval of novel glucosamine products
    • Focus of manufacturers on R&D activities in the field of glucosamine
  • Market Challenges
    • Several side effects associated with glucosamine

Porter's Five Forces: A Strategic Tool for Navigating the Glucosamine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glucosamine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glucosamine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glucosamine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glucosamine Market

A detailed market share analysis in the Glucosamine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glucosamine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glucosamine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glucosamine Market

A strategic analysis of the Glucosamine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glucosamine Market, highlighting leading vendors and their innovative profiles. These include Aden Healthcare, Andra Medi Pharma India Pvt. Ltd., Bio-gen Extracts Pvt. Ltd., Captek Softgel International Inc., Cargill, Inc., Cellmark AB, Enomark Pharma, Ethical Naturals Inc., Fabrichem, Inc., Fermentis Life Sciences, GlucosaGreen, Golden Shell Pharmaceutical Co. Ltd., Kabir Lifesciences, Koyo Chemical Co., Ltd., Lifecare Neuro Products Limited, Manus Aktteva Biopharma LLP, Panvo Organics Pvt Ltd., Pax Healthcare, Schiff Nutrition International Inc., SMPNutra, Spectrum Chemical Manufacturing Corp., TSI Health Sciences, Inc., United Laboratories, Inc., Velnex Medicare, Wellable Marine Biotech Holding Limited, and Zhejiang AOXING Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Glucosamine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Types, market is studied across Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride, and N-Acetylglucosamine.
  • Based on Form, market is studied across Capsules, Liquid, Powder, and Tablets.
  • Based on Source, market is studied across Animal and Plant. The Animal is further studied across Crab, Lobster, and Shrimp. The Plant is further studied across Corn and Mushrooom.
  • Based on Application, market is studied across Cosmetics, Dietary Supplements, Health Food, Medicine, and Veterinary.
  • Based on Distribution Channel, market is studied across Online Stores, Pharmacies, Retail Stores, and Supermarkets.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing obese population coupled with increasing number of arthritis cases
      • 5.1.1.2. Increasing use of glucosamine in bone and joint health supplements
      • 5.1.1.3. Rising need for glucosamine for the treatment of symptomatic osteoarthritis of the knee
    • 5.1.2. Restraints
      • 5.1.2.1. High cost related to glucosamine products
    • 5.1.3. Opportunities
      • 5.1.3.1. Launch and approval of novel glucosamine products
      • 5.1.3.2. Focus of manufacturers on R&D activities in the field of glucosamine
    • 5.1.4. Challenges
      • 5.1.4.1. Several side effects associated with glucosamine
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glucosamine Market, by Types

  • 6.1. Introduction
  • 6.2. Glucosamine Hydrochloride
  • 6.3. Glucosamine Sulfate Potassium Chloride
  • 6.4. Glucosamine Sulfate Sodium Chloride
  • 6.5. N-Acetylglucosamine

7. Glucosamine Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Liquid
  • 7.4. Powder
  • 7.5. Tablets

8. Glucosamine Market, by Source

  • 8.1. Introduction
  • 8.2. Animal
    • 8.2.1. Crab
    • 8.2.2. Lobster
    • 8.2.3. Shrimp
  • 8.3. Plant
    • 8.3.1. Corn
    • 8.3.2. Mushrooom

9. Glucosamine Market, by Application

  • 9.1. Introduction
  • 9.2. Cosmetics
  • 9.3. Dietary Supplements
  • 9.4. Health Food
  • 9.5. Medicine
  • 9.6. Veterinary

10. Glucosamine Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Online Stores
  • 10.3. Pharmacies
  • 10.4. Retail Stores
  • 10.5. Supermarkets

11. Americas Glucosamine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Glucosamine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Glucosamine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aden Healthcare
  • 2. Andra Medi Pharma India Pvt. Ltd.
  • 3. Bio-gen Extracts Pvt. Ltd.
  • 4. Captek Softgel International Inc.
  • 5. Cargill, Inc.
  • 6. Cellmark AB
  • 7. Enomark Pharma
  • 8. Ethical Naturals Inc.
  • 9. Fabrichem, Inc.
  • 10. Fermentis Life Sciences
  • 11. GlucosaGreen
  • 12. Golden Shell Pharmaceutical Co. Ltd.
  • 13. Kabir Lifesciences
  • 14. Koyo Chemical Co., Ltd.
  • 15. Lifecare Neuro Products Limited
  • 16. Manus Aktteva Biopharma LLP
  • 17. Panvo Organics Pvt Ltd.
  • 18. Pax Healthcare
  • 19. Schiff Nutrition International Inc.
  • 20. SMPNutra
  • 21. Spectrum Chemical Manufacturing Corp.
  • 22. TSI Health Sciences, Inc.
  • 23. United Laboratories, Inc.
  • 24. Velnex Medicare
  • 25. Wellable Marine Biotech Holding Limited
  • 26. Zhejiang AOXING Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLUCOSAMINE MARKET RESEARCH PROCESS
  • FIGURE 2. GLUCOSAMINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GLUCOSAMINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLUCOSAMINE MARKET DYNAMICS
  • TABLE 7. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE POTASSIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE SODIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GLUCOSAMINE MARKET SIZE, BY N-ACETYLGLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GLUCOSAMINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GLUCOSAMINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GLUCOSAMINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GLUCOSAMINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GLUCOSAMINE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GLUCOSAMINE MARKET SIZE, BY CRAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GLUCOSAMINE MARKET SIZE, BY LOBSTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GLUCOSAMINE MARKET SIZE, BY SHRIMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GLUCOSAMINE MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GLUCOSAMINE MARKET SIZE, BY CORN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GLUCOSAMINE MARKET SIZE, BY MUSHROOOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GLUCOSAMINE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GLUCOSAMINE MARKET SIZE, BY HEALTH FOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GLUCOSAMINE MARKET SIZE, BY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GLUCOSAMINE MARKET SIZE, BY VETERINARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GLUCOSAMINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GLUCOSAMINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GLUCOSAMINE MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GLUCOSAMINE MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 329. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 330. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023